Equivalent price position
This pack size cannot yet be normalized reliably for a unit-price comparison. MedInfoBase does not estimate unit prices from ambiguous pack descriptions.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Aprepitant
- Therapeutic area
- Gastrointestinal & hepatology
- Drug class
- Antiemetics
- ATC
- A04
- Strength
- 80 mg
- Dosage form
- Capsule
- Pack
- 80mg 2's & 125mg 1's
- Registration no.
- 101414
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-28 02:57
Manufacturer
Genome Pharmaceuticals (Pvt.) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (80mg 2's & 125mg 1's). Current price PKR 5,327.40, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Repitant 80 mg, 80mg 2's & 125mg 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/repitant-80-mg-101414-80mg-2s-125mg-1s-genome-pharmaceuticals-pvt-ltd/ (accessed 28 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 5,327.40 | 2026-07-27 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 101414Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
